Average Co-Inventor Count = 5.99
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (18 from 3,923 patents)
2. Other (1 from 832,843 patents)
3. Novartis Pharma Gmbh (8 patents)
19 patents:
1. 10183025 - Autotaxin inhibitors
2. 10117858 - Pyridine and pyrazine derivative for the treatment of CF
3. RE46757 - Pyridine and pyrazine derivative for the treatment of CF
4. 9763957 - Autotaxin inhibitors
5. 9365552 - Pyridine and pyrazine derivative for the treatment of CF
6. 9115087 - Squaramide derivatives as CXCR2 antagonist
7. 9018261 - Choline salt of an anti-inflammatory substituted cyclobutenedione compound
8. 8722925 - Squaramide derivatives as CXCR2 antagonist
9. 8476269 - Pyridine and pyrazine derivative for the treatment of CF
10. 8343966 - Organic compounds
11. 8329754 - Squaramide derivatives as CXCR2 antagonist
12. 8288588 - Squaramide derivatives as CXCR2 antagonist
13. 8247436 - Pyridine and pyrazine derivative for the treatment of CF
14. 8168654 - Quinuclidine derivatives binding to mucarinic M3 receptors
15. 8084463 - Quinuclidine derivatives and their use as muscarinic M3 receptor antagonists